Which combination of findings best supports a diagnosis of immune-mediated hemolytic anemia and what is an appropriate initial management step?

Prepare for the Veterinary IV CFE Test with flashcards and multiple choice questions. Each question includes hints and explanations. Ensure success with our comprehensive test prep!

Multiple Choice

Which combination of findings best supports a diagnosis of immune-mediated hemolytic anemia and what is an appropriate initial management step?

Immune-mediated hemolytic anemia causes red blood cell destruction by antibodies or complement, so the most supportive findings are a regenerative anemia with a marrow response, membrane changes from immune attack, and direct evidence of immune involvement. Reticulocytosis shows the bone marrow is trying to replace lost cells, spherocytes arise when antibody-coated cells lose membrane during partial phagocytosis, and a positive direct Coombs’ test confirms antibodies or complement on the red cells. Taken together, this pattern points to an immune-mediated destruction of RBCs. The appropriate initial management is to start corticosteroid therapy to suppress the immune response and reduce antibody production, which is the cornerstone of treatment for IMHA. Supportive care, such as IV fluids for hydration and stabilization, is important, and transfusion may be needed if the anemia is life-threatening, but addressing the immune attack with immunosuppression is the key first step. The other findings and approaches do not align with immune-mediated destruction and would not be as effective as this immunosuppressive strategy.

Immune-mediated hemolytic anemia causes red blood cell destruction by antibodies or complement, so the most supportive findings are a regenerative anemia with a marrow response, membrane changes from immune attack, and direct evidence of immune involvement. Reticulocytosis shows the bone marrow is trying to replace lost cells, spherocytes arise when antibody-coated cells lose membrane during partial phagocytosis, and a positive direct Coombs’ test confirms antibodies or complement on the red cells. Taken together, this pattern points to an immune-mediated destruction of RBCs.

The appropriate initial management is to start corticosteroid therapy to suppress the immune response and reduce antibody production, which is the cornerstone of treatment for IMHA. Supportive care, such as IV fluids for hydration and stabilization, is important, and transfusion may be needed if the anemia is life-threatening, but addressing the immune attack with immunosuppression is the key first step. The other findings and approaches do not align with immune-mediated destruction and would not be as effective as this immunosuppressive strategy.

More practice questions